Vedolizumab (rch)
Consumer Medicine Information (CMI)
What is in this leaflet
This leaflet answers some common questions about Entyvio.
It does not contain all the available information. It does not take the place of talking
to your doctor or pharmacist.
The information in this leaflet was last updated on the date listed on the final page.
More recent information on the medicine may be available. You should ensure that you
speak to your pharmacist or doctor to obtain the most up to date information on this
medicine. You can also download the most up to date leaflet from https://www.ebs.tga.gov.au/.
Those updates may contain important information about the medicine and its use of
which you should be aware.
All medicines have risks and benefits. Your doctor has weighed the risks of you being
given this medicine against the benefits they expect it will have for you.
If you have any concerns about being given this medicine, ask your doctor or pharmacist.
Keep this leaflet with the medicine.
You may need to read it again.
What Entyvio is used for
Entyvio contains the active substance vedolizumab, a monoclonal antibody. Monoclonal
antibodies are proteins that recognise and bind to certain special proteins in the
body.
Entyvio specifically binds to a protein called integrin α4β7 present on certain white blood cells. Integrin α4β7 can act to increase inflammation seen in ulcerative colitis and Crohn’s disease.
Entyvio works by blocking α4β7 integrins and so reduces inflammation.
Ulcerative colitis
Ulcerative colitis is an inflammatory disease of the large bowel. Entyvio is used
to treat the signs and symptoms of moderate to severe ulcerative colitis in adults
who have not responded well enough or are intolerant to other treatments.
Crohn’s disease
Crohn’s disease is an inflammatory disease of the bowel. It may also affect any part
of the gut. Entyvio is used to treat the signs and symptoms of moderate to severe
Crohn’s disease in adults who have not responded well enough or are intolerant to
other treatments.
Ask your doctor or pharmacist if you have any questions about why Entyvio has been
prescribed for you.
Your doctor may have prescribed it for another purpose.
This medicine is available only with a doctor’s prescription.
There is not enough information to recommend the use of this medicine for children
under the age of 18 years.
Before you are given Entyvio
When you must not be given it
You should not be given Entyvio if you:
are allergic to vedolizumab or any of the other ingredients listed at the end of this
leaflet.
Symptoms of an allergic reaction may include wheezing, difficulty breathing, hives,
itching, swelling or dizziness.
have an active severe infection, such as for example tuberculosis, blood poisoning,
serious abscesses.
Do not receive it after the expiry date printed on the pack or if the packaging is
damaged or shows signs of tampering.
If it has expired or is damaged return it to your pharmacist for disposal.
Before you are given it
Tell your doctor if:
you have an infection, or think you have an infection.
are going to receive any vaccination or have recently had a vaccination.
Entyvio may affect the way you respond to a vaccination
you have any allergies to any other medicines, foods, preservatives or dyes.
Tell your doctor if you are pregnant or intend to become pregnant.
The effects of Entyvio in pregnant women are not known. Therefore, this medicine is
not recommended for use during pregnancy unless you and your doctor decide that the
benefit to you clearly outweighs the potential risk to your baby.
Your doctor can discuss the risks and benefits involved.
If you are a woman of childbearing potential, you should use adequate contraception
to avoid falling pregnant and continue to use it for at least 4.5 months after the
last treatment with Entyvio.
Tell your doctor if you are breastfeeding or intend to breastfeed.
Entyvio passes into breast milk and it is not known what effect this may have on your
baby. If you are breastfeeding, your doctor may advise you to stop breastfeeding while
you are using this medicine.
If you have not told your doctor about any of the above, tell them before you are
given Entyvio.
Taking other medicines
Tell your doctor or pharmacist if you are taking any other medicines, including any
that you buy without a prescription from your pharmacy, supermarket or health food
store.
Entyvio should not be given with other biologic medicines that suppress your immune
system as this combination has not been studied in clinical trials.
If you have previously taken natalizumab (TYSABRI) or rituximab (MABTHERA) for other
conditions, tell your doctor who will decide if you can be given Entyvio.
How Entyvio is given
Entyvio will be given to you by your doctor or nurse, through a drip in one of the
veins in your arm (intravenous infusion) over about 30 minutes.
Your healthcare provider will monitor you during and after the Entyvio infusion for
side effects to see if you have a reaction to the treatment.
If you have any questions about how this medicine is given, ask your doctor or nurse
who is giving you the infusion.
How much to take
Treatment with Entyvio is the same for ulcerative colitis and Crohn’s disease.
The recommended dose of Entyvio is 300 mg per infusion. Following the initial dose,
you will get additional infusions at 2 and 6 weeks and be assessed by your treating
doctor 6 to 8 weeks after you’ve completed the initial treatment doses to see how
you have responded. For patients with Crohn’s Disease who have not shown response,
your doctor may recommend an additional dose of Entyvio at week 10.
If there has been an adequate response to the first 3 doses you may continue treatment
with further doses every 8 weeks. Your doctor may decide to alter this treatment schedule
to every 4 weeks depending on how well Entyvio works for you.
How long to take it
Continue receiving your medicine for as long as your doctor tells you.
You should not stop using Entyvio without talking with your doctor first.
If you forget or miss an appointment
If you forget or miss an appointment to receive the infusion, make another appointment
as soon as possible.
If you are not sure what to do, ask your doctor.
If you are given too much (overdose)
As Entyvio is given to you by infusion under the supervision of a doctor or nurse,
it is unlikely that you will receive too much.
However, if you experience any side effects after being given Entyvio, tell your doctor
or nurse immediately.
While you are being given Entyvio
Things you must do
When you first receive this medicine and during the course of the treatment, also
between doses, tell your doctor or nurse immediately if you:
experience blurred, loss of or double vision, difficulty speaking, weakness in an
arm or a leg, a change in the way you walk or problems with your balance, persistent
numbness, decreased sensation or loss of sensation, or memory loss or confusion. These
may all be symptoms of a serious and potentially fatal brain condition known as progressive
multifocal leukoencephalopathy (PML).
Your doctor or nurse will provide you with a Patient Alert Card, that you should keep
with you at all times. This card will remind you to tell all other health professionals
that you are being given Entyvio.
If you experience any of the symptoms in this card, you should contact your doctor
immediately.
have an infection, or think you have an infection, such as if you develop chills,
shivering, persistent cough or a high fever.
Some infections may become serious and possibly even life-threatening if left untreated
experience signs of an allergic reaction or other reaction to the infusion such as
wheezing, difficulty breathing, hives, itching, swelling or dizziness.
These could occur during or after the infusion.
are going to receive any vaccination or have recently had a vaccination.
Entyvio may affect the way you respond to a vaccination
If you are about to be started on any new medicine, remind your doctor that you are
taking Entyvio.
If you become pregnant while you are taking this medicine, tell your doctor immediately.
Things you must not do
Do not use this medicine to treat any other complaints unless your doctor tells you
to.
Do not give this medicine to anyone else, even if they have the same condition as
you.
Do not stop taking Entyvio without checking with your doctor.
Things to be careful of
Be careful driving or operating machinery until you know how Entyvio affects you.
This medicine may have a minor influence on your ability to drive or use tools or
machines. A small number of patients have felt dizzy after receiving Entyvio.
If you feel dizzy, do not drive or use tools or machines.
Side effects
Tell your doctor or pharmacist as soon as possible if you do not feel well while you
are taking Entyvio.
Entyvio helps most people with ulcerative colitis or Crohn’s disease, but it may have
unwanted side effects in a few people.
All medicines have some unwanted side effects. Sometimes they are serious, but most
of the time they are not. You may need medical attention if you get some of the side-effects.
Do not be alarmed by this list of possible side effects. You may not experience any
of them.
Ask your doctor or pharmacist to answer any questions you may have.
Tell your doctor or nurse if you notice any of the following and they worry you:
headache
fever
common cold
flu (influenza)
nose or throat infection
bronchitis
chest infection
cough
throat pain
nausea
itching
rash and redness
pain in the extremities
back pain
joint pain
tiredness
The above list includes the more common side effects of your medicine. They are usually
mild and short-lived.
Tell your doctor as soon as possible if you notice any of the following:
high fever
rash
dark urine, yellowing of the eyes and skin (jaundice)
The above symptoms could be a sign of infection or liver injury. Some infections may
become serious and possibly even life-threatening if left untreated.
If any of the following happen, tell your doctor immediately or go to Accident and
Emergency at your nearest hospital:
wheezing or difficulty breathing
hives
itching of the skin
swelling
rapid heart beat
vomiting
chills or shivering
The above list includes very serious side effects. You may need urgent medical attention.
These side effects are rare.
Tell your doctor or pharmacist if you notice anything else that is making you feel
unwell.
Other side effects not listed above may occur in some people.
Storage
If you need to store Entyvio before taking it to hospital or clinic, the unopened
vial should be stored in the refrigerator at 2°C to 8°C (Refrigerate. Do not freeze).
Protect from light. Keep the vial in the original carton.
Do not store it or any other medicine in the bathroom, near a sink, or on a windowsill.
Do not leave it in the car.
Heat and damp can destroy some medicines.
Keep it where children cannot reach it.
Product description
What it looks like
Entyvio is a white to off-white powder provided in a glass vial.
Each pack of Entyvio contains one vial.
Ingredients
Active ingredient:
Each vial of Entyvio contains 300 mg of vedolizumab.
After reconstitution each mL of solution contains 60 mg of vedolizumab.
Other ingredients:
histidine
histidine hydrochloride monohydrate
arginine hydrochloride
sucrose
polysorbate 80
Supplier
Entyvio is supplied in Australia by:
Takeda Pharmaceuticals Australia Pty Ltd
Level 39
225 George Street Sydney, NSW 2000 Australia Tel: 1800 675 957 www.takeda.com/en-au
This leaflet was prepared in May 2020.
Australian Registration Number
AUST R 210048
ENTYVIO® is a registered trademark of Millennium Pharmaceuticals, Inc. TAKEDA® and the TAKEDA Logo® are registered trademarks of Takeda Pharmaceutical Company Limited.